JHOANA TOVAR: Open Payments
NPI 1649868191 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 29 payments from 18 companies in 2025. Trend: 2023 $259 · 2024 $385 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| Madrigal Pharmaceuticals | 3 | $100 |
| GlaxoSmithKline, LLC. | 2 | $64 |
| Novo Nordisk Inc | 3 | $56 |
| PFIZER INC. | 3 | $45 |
| Gilead Sciences, Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: TEZSPIRE, REZDIFFRA, AREXVY, NURTEC ODT, BEXSERO, GIVLAARI, ACTHAR, GARDASIL 9.
Industry payments across CA — which companies pay providers there.
